Cell mediated cytotoxicity and cytokine production in peripheral blood mononuclear cells of glioma patients

Cassone, 1987, Cell wall of Candida albicans and host response, Crit Rev Microbiol, 1, 87, 10.3109/10408418709104451 Ausiello, 1986, Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions, J Med Microbiol, 22, 195, 10.1099/00222615-22-3-195 Ausiello, 1989, Cytotoxic effectors in human peripheral blood mononuclear cells induced by a mannoprotein complex of Candida albicans: a comparison with interleukin-2 activated killer cells, Cell Immunol, 121, 349, 10.1016/0008-8749(89)90033-6 Scaringi, 1988, Cell wall components of Candida albicans as immunomodulators: induction of natural killer as macrophage-mediated peritoneal cell cytotoxicity in mice by mannoprotein and glucan fractions, J Gen Microbiol, 134, 1265 Vecchiarelli, 1989, Protective immunity induced by low-virulence Candida albicans, 124, 334 Brooks, 1972, Depressed cell-mediated immunity in patients with primary intracranial tumors, 136, 1631 Neuwelt, 1983, Immune responses in patients with brain tumors, 51, 248 Schwyzer, 1985, Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells, J Immunol, 134, 1003 Ausiello, 1988, Cell-mediated cytotoxicity in glioma-bearing patients: differential responses of peripheral blood mononuclear cells to stimulation with interleukin-2 and microbial antigen, J Neurol-Oncol, 6, 329 Grimm, 1982, Lymphokine activated killer cell phenomenon. I: Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologus human peripheral blood lymphocytes, J Exp Med, 155, 1823, 10.1084/jem.155.6.1823 Herberman, 1987, Lymphokine-activated killer cell activity, Immunol Today, 8, 178, 10.1016/0167-5699(87)90035-1 Torosantucci, 1990, Characterization of lymphoproliferative and cytotoxic responses of human peripheral blood mononuclear cells to mannoprotein costituents of Candida albicans, J Gen Microbiol, 136, 2155, 10.1099/00221287-136-11-2155 Knapp, 1989, Towards a better definition of human leucocyte surface molecules, Immunol Today, 10, 253, 10.1016/0167-5699(89)90135-7 Gillis, 1978, T cell growth factor: parameters of production and a quantitative microassay for activity, J Immunol, 120, 2077 Thiele, 1986, Leu-leu-OMe sensitivity of human activated killer cells: delineation of distinct class of cytotoxic T lymphocytes capable of lysing tumor targets, J Immunol, 137, 1399 Giovarelli, 1988, Obligatory role of IFN-gamma in induction of lymphokine-activated and T lymphocyte killer activity but not in boosting of natural cytotoxicity, J Immunol, 141, 2831 Limb, 1989, Release of cytokines during generation of lymphokine-activated killer (LAK) cells by IL-2, Immunology, 68, 514 Siepl, 1988, The glioblastoma-derived T cell suppressor factor/transforming growth factor-β2 inhibits T cell growth without affecting the interaction of interleukin 2 with its receptor, Eur J Immunol, 18, 593, 10.1002/eji.1830180416 Braun, 1984, Regulation of natural killer cell function by glass-adherent cells in patients with primary intracranial malignancies, J Neurosurg, 15, 29, 10.1227/00006123-198407000-00007 Ullen, 1986, Natural killer activity of blood lymphocytes in patients with primary intracranial tumors, 10, 1239 Maraskovsky, 1989, IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells, J Immunol, 143, 1210 Li, 1989, Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alfa and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes, Cancer Res, 49, 5979 Gemlo, 1988, Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin and lymphokine-activated killer cells, Cancer Res, 48, 5864 Elliott, 1984, Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors, J Immunol, 132, 1208